NIH SBIR Phase I Biomedical & Health Technology Grant

Program Summary & Scope

NIH SBIR grants support early-stage commercialization of innovative biomedical, clinical, and life science technologies. Phase I focuses on establishing technical merit and proof-of-concept for groundbreaking therapeutics and medical devices.

Key Requirements & Eligibility Criteria

• Supports R&D for therapeutics, diagnostics, medical devices, and health IT
• Direct-to-Phase II pathway available for qualifying companies with preliminary data
• Allows subcontracting to academic research institutions